Identifying tests related to breast cancer care in claims data

doi:10.1111/tbj.13691

. 2020 Jun;26(6):1227-1230.

doi: 10.1111/tbj.13691. Epub 2019 Nov 18.

Identifying tests related to breast cancer care in claims data

Benjamin L Franc¹, Robert Thombley², Yanting Luo², W John Boscardin³, Hope S Rugo⁴, David Seidenwurm⁵, R Adams Dudley²

Affiliations

¹ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
² Philip R. Lee Institute for Health Policy Studies, Center for Healthcare Value, University of California, San Francisco, CA, USA.
³ Department of Medicine, Epidemiology & Biostatistics, San Francisco, CA, USA.
⁴ Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
⁵ Sutter Medical Foundation, Sacramento, CA, USA.

PMID: 31736191
PMCID: PMC7304302
DOI: 10.1111/tbj.13691

Identifying tests related to breast cancer care in claims data

Benjamin L Franc et al. Breast J. 2020 Jun.

. 2020 Jun;26(6):1227-1230.

doi: 10.1111/tbj.13691. Epub 2019 Nov 18.

Authors

Benjamin L Franc¹, Robert Thombley², Yanting Luo², W John Boscardin³, Hope S Rugo⁴, David Seidenwurm⁵, R Adams Dudley²

Affiliations

¹ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
² Philip R. Lee Institute for Health Policy Studies, Center for Healthcare Value, University of California, San Francisco, CA, USA.
³ Department of Medicine, Epidemiology & Biostatistics, San Francisco, CA, USA.
⁴ Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
⁵ Sutter Medical Foundation, Sacramento, CA, USA.

PMID: 31736191
PMCID: PMC7304302
DOI: 10.1111/tbj.13691

Abstract

To develop a method for calculating rates of testing for breast cancer recurrence in patients who have already undergone initial treatment for breast cancer, we calculated rates in a cohort of Medicare breast cancer patients and an age-matched noncancer cohort. We first used only tests with claims including diagnosis codes indicating invasive breast cancer and then used all tests regardless of diagnosis code. For each method, we calculated testing rates in the breast cancer cohort above the background rate in the noncancer population. The two methods provided similar estimates of testing prevalence and frequency, with exception of prevalence of CT.

Keywords: breast cancer; imaging utilization; surveillance epidemiology and end results; test utilization.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Notification: None

References

1. Liu TW, et al., Increasing Receipt of High-Tech/High-Cost Imaging and Its Determinants in the Last Month of Taiwanese Patients With Metastatic Cancer, 2001–2010: A Retrospective Cohort Study. Medicine (Baltimore), 2015. 94(32): p. e1354. - PMC - PubMed
1. Chang SM, et al., Patterns of care for adults with newly diagnosed malignant glioma. JAMA, 2005. 293(5): p. 557–64. - PubMed
1. Primrose JN, et al., Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA, 2014. 311(3): p. 263–70. - PubMed
1. Franc BL, et al., Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer. J Natl Compr Canc Netw, 2018. 16(7): p. 829–837. - PubMed
1. Wang YA, Feng AC, and Ganz PA, Health services utilisation in breast cancer survivors in Taiwan. Sci Rep, 2014. 4: p. 7466. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Liu TW, et al., Increasing Receipt of High-Tech/High-Cost Imaging and Its Determinants in the Last Month of Taiwanese Patients With Metastatic Cancer, 2001–2010: A Retrospective Cohort Study. Medicine (Baltimore), 2015. 94(32): p. e1354. - PMC - PubMed

[2] Liu TW, et al., Increasing Receipt of High-Tech/High-Cost Imaging and Its Determinants in the Last Month of Taiwanese Patients With Metastatic Cancer, 2001–2010: A Retrospective Cohort Study. Medicine (Baltimore), 2015. 94(32): p. e1354. - PMC - PubMed

[3] Chang SM, et al., Patterns of care for adults with newly diagnosed malignant glioma. JAMA, 2005. 293(5): p. 557–64. - PubMed

[4] Chang SM, et al., Patterns of care for adults with newly diagnosed malignant glioma. JAMA, 2005. 293(5): p. 557–64. - PubMed

[5] Primrose JN, et al., Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA, 2014. 311(3): p. 263–70. - PubMed

[6] Primrose JN, et al., Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA, 2014. 311(3): p. 263–70. - PubMed

[7] Franc BL, et al., Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer. J Natl Compr Canc Netw, 2018. 16(7): p. 829–837. - PubMed

[8] Franc BL, et al., Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer. J Natl Compr Canc Netw, 2018. 16(7): p. 829–837. - PubMed

[9] Wang YA, Feng AC, and Ganz PA, Health services utilisation in breast cancer survivors in Taiwan. Sci Rep, 2014. 4: p. 7466. - PMC - PubMed

[10] Wang YA, Feng AC, and Ganz PA, Health services utilisation in breast cancer survivors in Taiwan. Sci Rep, 2014. 4: p. 7466. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Identifying tests related to breast cancer care in claims data

Affiliations

Identifying tests related to breast cancer care in claims data

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical